Early experience of percutaneous paravalvular leak closure using a novel Occlutech occluder

Abstract

The novel Occlutech Paravalvular Leak Device, which was designed specifically for mitral and aortic paravalvular regurgitation, is an additional, useful tool in the device armamentarium for the treatment of PVL.

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

“…143,[145][146][147][148][149][150][151][152][153][154][155][156][157][158][159][160]162 IIa B A bioprosthesis is reasonable for patients more than 70 years of age. [163][164][165][166] 2014 recommendation remains current.…”

EchoNavigator® technology facilitates transapical mitral paravalvular leak closure: a case report

“…A specifically designed CE-marked device like PLD, available in 4 different shapes and 19 different sizes, might allow PVL closure to be performed more conveniently and efficaciously, mostly often with one single occluder. 13 , 14 , 15 …”

Transcatheter Closure of a Mitral Valve Paravalvular Leak in an Infant

“…A trans-apical approach is also feasible, with the benefit of allowing direct entry of the mitral PVL regardless of its location; this can be performed percutaneously or open [2]. Disadvantages to a percutaneous apical approach are that it is more invasive and requires additional pre-procedure planning and imaging (i.e., ultrasound, echocardiography, and/ or computed tomography) and that there is limited availability of dedicated apical closure devices domestically or internationally [5][6][7]. The open approach has additional limitations, such as an increased risk of apical tear, bleeding, myocardial damage, arrhythmia, coronary damage, and infection.…”